Two New Treatments for Advanced Melanoma Approved by FDA

On Wednesday the US Food and Drug Administration announced that it has approved two new oral medications for the treatment of metastatic or advanced melanoma that is non-operable–Tafinlar and Mekinist–both of which are marketed by GlaxoSmithKline. Both drugs are to be used as a mono-therapy–not combined with other treatments. Still the best treatment for melanoma is early detection and complete surgical removal.

Advertisements

We want to know what you think. Leave a Reply.

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s